Familial idiopathic basal ganglia calcification (Fahr’s disease)

References

1. ↵
   1. Manyam BV

   (2005) What is and what is not ‘Fahr's disease’ Parkinsonism Relat Disord 11, 73–80.
2. ↵
   1. Beall SS,
   2. Patten BM,
   3. Mallette L,
   4. Jankovic J

   (1989) Abnormal systemic metabolism of iron, porphyrin, and calcium in Fahr's syndrome. Ann Neurol 26, 569–575.
3. ↵
   1. Kobari M,
   2. Nogawa S,
   3. Sugimoto Y,
   4. Fukuuchi Y

   (1997) Familial idiopathic brain calcification with autosomal dominant inheritance. Neurology 48, 645–649.
4. ↵
   1. Kim SH,
   2. Yoo BG,
   3. Kim KS,
   4. Yoo KM,
   5. Joh YD

   (2003) Familial idiopathic striopallidodentate calcifications. J Korean Neurol Assoc 21, 191–194.
5. ↵
   1. Geschwind DH,
   2. Loginov M,
   3. Stern JM

   (1999) Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr disease). Am J Hum Genet 65, 764–772.
6. ↵
   1. Yarlagadda A,
   2. Kaushik S,
   3. Clayton AH

   (2007) Blood brain barrier: the role of calcium homeostasis. Psychiatry (Edgmont) 42, 55–59.
7. ↵
   1. Malik R,
   2. Pandya VK,
   3. Naik D

   (2004) Fahr disease - A rare neurodegenerative disorder. Indian Journal of Radiology and Imaging 14, 383–384.
8. ↵
   1. Manyam BV,
   2. Bhatt MH,
   3. Moore WD,
   4. Devleschoward AB,
   5. Anderson DR,
   6. Calne DB

   (1992) Bilateral striopallidodentate calcinosis: cerebrospinal fluid, imaging, and electrophysiological studies. Ann Neurol 31, 379–384.
9. ↵
   1. Hozumi I,
   2. Kohmura A,
   3. Kimura A,
   4. Hasegawa T,
   5. Honda A,
   6. Hayashi Y,
   7. et al.

   (2010) High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease. Case Rep Neurol 2, 46–51.
10. ↵
    1. Uygur GA,
    2. Liu Y,
    3. Hellman RS,
    4. Tikofsky RS,
    5. Collier BD

    (1995) Evaluation of regional cerebral blood flow in massive intracerebral calcifications. J Nucl Med 36, 610–702.
11. ↵
    1. Benke T,
    2. Karner E,
    3. Seppi K,
    4. Delazer M,
    5. Marksteiner J,
    6. Donnemiller E

    (2004) Subacute dementia and imaging correlates in a case of Fahr's disease. J Neurol Neurosurg Psychiatry 75, 1163–1165.
12. ↵
    1. Pagon RA,
    2. Adam MP,
    3. Ardinger HH,
    4. Bird TD,
    5. Dolan CR,
    6. Fong CT,
    7. et al.

    1. Sobrido MJ,
    2. Coppola G,
    3. Oliveira J,
    4. Hopfer S,
    5. Geschwind DH

    Primary Familial Brain Calcification. in GeneReviews™ [Internet]. 2004 Apr 18 [Updated 2013 Jun 27], eds Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, et al. (University of Washington 1993-2014, Seattle (WA)) Available from: http://www.ncbi.nlm.nih.gov/books/NBK1421.
13. ↵
    1. Bostan AC,
    2. Strick PL

    (2010) The cerebellum and basal ganglia are interconnected. Neuropsychol Rev 20, 261–270.
14. ↵
    1. Tarsy D,
    2. Vitek JL,
    3. Starr PA,
    4. Okun MS

    1. Haber SN

    (2008) Functional Anatomy and Physiology of the Basal Ganglia: Non-motor Functions. in Deep Brain Stimulation in Neurological and Psychiatric Disorders, eds Tarsy D, Vitek JL, Starr PA, Okun MS (Humana Press, Totowa (NJ)), 33–62.
15. ↵
    1. Ring HA,
    2. Serra-Mestres JS

    (2002) Neuropsychiatry of the basal ganglia. J Neurol Neurosurg Psychiatry 72, 12–21.
16. ↵
    1. Raunch SL,
    2. Savage CR

    (1997) Neuroimaging and neuropsychology of the striatum. Bridging basic science and clinical practice. Psychiatry Clin North Am 20, 741–768.
17. ↵
    1. Schultz W,
    2. Tremblay L,
    3. Hollerman JR

    (1998) Reward prediction in primate basal ganglia and frontal cortex. Neuropharmacology 37, 421–429.
18. ↵
    1. Lauterbach EC,
    2. Cummings JL,
    3. Duffy J,
    4. Coffey CE,
    5. Kaufer D,
    6. Lovell M,
    7. et al.

    (1998) Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci 10, 249–266.
19. ↵
    1. Abubakar SA,
    2. Saidu S

    (2012) Idiopathic bilateral strio-pallido-dentate calcinosis (Fahr's disease): a case report and review of the literature. Ann Afr Med 11, 234–237.
20. ↵
    1. Lazar M,
    2. Ion DA,
    3. Streinu-Cercel A,
    4. Badarau AI

    (2009) Fahr's syndrome: diagnosis issues in patients with unknown family history of disease. Rom J Morphol Embryol 50, 425–428.
21. ↵
    1. Trautner RJ,
    2. Cummings JL,
    3. Read SL,
    4. Benson DF

    (1988) Idiopathic basal ganglia calcification and organic mood disorder. Am J Psychiatry 145, 350–353.
22. ↵
    1. Shakibai SV,
    2. Johnson JP,
    3. Bourgeois JA

    (2005) Paranoid delusions and cognitive impairment suggesting Fahr's disease. Psychosomatics 46, 569–572.
23. 1. Srivastava S,
    2. Bhatia MS,
    3. Sharma V,
    4. Mahajan S,
    5. Rajender G

    (2010) Fahr's Disease: An Incidental Finding in a Case Presenting with Psychosis. German Journal of Psychiatry 13, 86–90.
24. ↵
    1. Kao YC,
    2. Lin MI

    (2010) Intramuscular hemangioma of the temporalis muscle with incidental finding of bilateral symmetric calcification of the basal ganglia: a case report. Pediatr Neonatol 51, 296–299.
25. ↵
    1. Konig P

    (1989) Psychopathological alterations in cases of symmetrical basal ganglia sclerosis. Biol Psychiatry 25, 459–468.
26. ↵
    1. Ghormode D,
    2. Maheshwari U,
    3. Kate N,
    4. Grover S

    (2011) Fahr's disease and psychiatric syndromes: A case series. Ind Psychiatry J 20, 136–138.
27. ↵
    1. Shoyama M,
    2. Kitabata Y,
    3. Kaku T,
    4. Shinosaki K

    (2005) Evaluation of regional cerebral blood flow in Fahr disease with schizophrenia-like psychosis: a case report. AJNR Am J Neuroradiol 26, 2527–2529.
28. ↵
    1. Shibayama H,
    2. Kobayashi H,
    3. Nakagawa M,
    4. Yamada K,
    5. Iwata H,
    6. Iwai K,
    7. et al.

    (1992) Non-Alzheimer non-Pick dementia with Fahr's syndrome. Clin Neuropathol 11, 237–250.
29. ↵
    1. Lam JS,
    2. Fong SY,
    3. Yiu GC,
    4. Wing YK

    (2007) Fahr's disease: a differential diagnosis of frontal lobe syndrome. Hong Kong Med J 13, 75–77.
30. ↵
    1. Massano J,
    2. Bhatia KP

    (2012) Clinical approach to Parkinson's disease: features, diagnosis, and principles of management. Cold Spring Harb Perspect Med 2, a008870.
31. ↵
    1. Manyam BV,
    2. Walters AS,
    3. Naria KR

    (2001) Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Mov Disord 16, 258–264.
32. ↵
    1. Alvarez MV,
    2. Evidente VG

    (2008) Understanding drug-induced parkinsonism: separating pearls from oysters. Neurology 70, 32–34.
33. ↵
    1. Manabe Y,
    2. Araki M,
    3. Takeda K,
    4. Yokota S,
    5. Kimura T

    (1989) Pseudohypoparathyroidism with striopallidodentate calcification--a case report and review of the literature. Jpn J Med 28, 391–395.
34. ↵
    1. Mufaddel A,
    2. Alsabousi M,
    3. Salih B,
    4. Alhassani G,
    5. Osman OT

    (Aug 20, 2013) A case of Gorling-Goltz syndrome presented with psychiatric features. Behav Neurol, Epub ahead of print.
35. ↵
    1. Makariou E,
    2. Patsalides AD

    (2009) Intracranial calcifications. Applied Radiology 38, 48–60.
36. ↵
    1. Celzo FG,
    2. Venstermans C,
    3. De Belder F,
    4. Van Goethem J,
    5. van den Hauwe L,
    6. van der Zijden T,
    7. et al.

    (2013) Brain stones revisited-between a rock and a hard place. Insights Imaging 4, 625–635.
37. ↵
    1. Skvortsov IA,
    2. Rudenskaia GE,
    3. Karaseva AN,
    4. Vel’tishchev IuE

    (1987) [Effectiveness of therapeutic use of complexones in various diseases of the extrapyramidal system in children]. Zh Nevropatol Psikhiatr Im S S Korsakova 87, 1457–1462.